PURPOSE: Limited data exist on differences of erythema migrans patients with either positive or negative Borrelia burgdorferi sensu lato skin culture. METHODS: We analyzed 252 adult patients with erythema migrans in whom skin biopsy specimen was cultured for the presence of B. burgdorferi sensu lato. Evaluations of epidemiological, clinical, and microbiological findings were conducted at baseline, 14 days, 2, 6, and 12 months after treatment with either doxycycline or cefuroxime axetil. RESULTS: One hundred fifty-one (59.9%) patients had positive skin culture (86.9% B. afzelii, 8.0% B. garinii, 5.1% B. burgdorferi sensu stricto) and 101 (40.1%) had negative skin culture. Patients in the culture-positive and culture-negative groups were comparable for the basic demographic, epidemiological, clinical, and laboratory characteristics at presentation. Statistically significantly worse selected treatment outcome parameters in the culture-positive group compared with the culture-negative group were established during follow-up. Treatment failure was documented in two patients who were culture positive and in none in the culture-negative group. CONCLUSIONS: Although findings for the pretreatment characteristics were comparable between the erythema migrans skin culture-positive and culture-negative patients, some parameters indicate that borrelia skin culture positivity may predict a less-favorable treatment outcome.
PURPOSE: Limited data exist on differences of erythema migranspatients with either positive or negative Borrelia burgdorferi sensu lato skin culture. METHODS: We analyzed 252 adult patients with erythema migrans in whom skin biopsy specimen was cultured for the presence of B. burgdorferi sensu lato. Evaluations of epidemiological, clinical, and microbiological findings were conducted at baseline, 14 days, 2, 6, and 12 months after treatment with either doxycycline or cefuroxime axetil. RESULTS: One hundred fifty-one (59.9%) patients had positive skin culture (86.9% B. afzelii, 8.0% B. garinii, 5.1% B. burgdorferi sensu stricto) and 101 (40.1%) had negative skin culture. Patients in the culture-positive and culture-negative groups were comparable for the basic demographic, epidemiological, clinical, and laboratory characteristics at presentation. Statistically significantly worse selected treatment outcome parameters in the culture-positive group compared with the culture-negative group were established during follow-up. Treatment failure was documented in two patients who were culture positive and in none in the culture-negative group. CONCLUSIONS: Although findings for the pretreatment characteristics were comparable between the erythema migrans skin culture-positive and culture-negative patients, some parameters indicate that borrelia skin culture positivity may predict a less-favorable treatment outcome.
Authors: Daša Stupica; Lara Lusa; Vera Maraspin; Petra Bogovič; Darja Vidmar; Maria O'Rourke; Andreas Traweger; Ian Livey; Franc Strle Journal: PLoS One Date: 2015-09-09 Impact factor: 3.240
Authors: F R van de Schoor; M E Baarsma; S A Gauw; L A B Joosten; B J Kullberg; C C van den Wijngaard; J W Hovius Journal: BMC Infect Dis Date: 2019-08-20 Impact factor: 3.090
Authors: Agnetha Hofhuis; Tineke Herremans; Daan W Notermans; Hein Sprong; Manoj Fonville; Joke W B van der Giessen; Wilfrid van Pelt Journal: PLoS One Date: 2013-05-16 Impact factor: 3.240
Authors: Maria O'Rourke; Andreas Traweger; Lara Lusa; Dasa Stupica; Vera Maraspin; P Noel Barrett; Franc Strle; Ian Livey Journal: PLoS One Date: 2013-05-16 Impact factor: 3.240